Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 14, 2015 - Issue 3
Submit an article Journal homepage
661
Views
10
CrossRef citations to date
0
Altmetric
Review

Safety of subcutaneous versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

Maeve McLaughlinAddenbrooke’s Hospital, Rheumatology Research Unit, Box 204, Cambridge Biomedical Campus, Hills Road, Cambridge, UK
, MBBS (Lond) MA (Cantab) MRCP (Rheumatology Clinical Research Fellow) &
Andrew Östör’sCambridge University, School of Clinical Medicine, Cambridge, UK+44 1223 245 151; [email protected]
, MA MB BS FRACP FRCP FRCP (Edin) (Rheumatology Consultant, Associate Lecturer, Director of the Cambridge Rheumatology Research Unit)
Pages 429-437 | Published online: 02 Jan 2015

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Filip Machaj, Jakub Rosik, Bartosz Szostak & Andrzej Pawlik. (2020) The evolution in our understanding of the genetics of rheumatoid arthritis and the impact on novel drug discovery. Expert Opinion on Drug Discovery 15:1, pages 85-99.
Read now
Michael Schirmer, Francesco Muratore & Carlo Salvarani. (2018) Tocilizumab for the treatment of giant cell arteritis. Expert Review of Clinical Immunology 14:5, pages 339-349.
Read now
Emma Mitchell & Graeme Jones. (2016) Subcutaneous tocilizumab for the treatment of rheumatoid arthritis. Expert Review of Clinical Immunology 12:2, pages 103-114.
Read now

Articles from other publishers (7)

Hui-lin Zeng, Qian Qiu, Ting-xiong Fu, Ai-ping Deng & Xiang-yang Xie. (2023) Development and optimization of sustained release triptolide microspheres. PLOS ONE 18:10, pages e0292861.
Crossref
Mohamed-Yacine Khitri, Alessandra Bartoli, Georgina Maalouf, Alban Deroux, Carlo Salvarani, Giacomo Emmi, Omer Karadag, Gerard Espinosa, Mathilde Leclercq, Gabriele Simonini, Mathieu Vautier, Patrice Cacoub & David Saadoun. (2023) Tocilizumab in Behçet Disease: A Multicenter Study of 30 Patients. The Journal of Rheumatology 50:7, pages 916-923.
Crossref
Dan Huang, Jian Liu, Ling Xin, Jin-gui Xie, Qiang Zhu, Pei-sheng Chen, Zhi-bin Shen, Qing-he Meng & Hai-yan Wang. (2020) Data Mining Study on Prescription Patterns of Different Dosage Forms of Chinese Herbal Medicines for Treating and Improving Immune-Inflammatory Indices in Patients with Rheumatoid Arthritis. Chinese Journal of Integrative Medicine 28:3, pages 215-222.
Crossref
Mitsuhiro Akiyama, Yuko Kaneko & Tsutomu Takeuchi. (2020) Effectiveness of tocilizumab in Behcet's disease: A systematic literature review. Seminars in Arthritis and Rheumatism 50:4, pages 797-804.
Crossref
Bong-Ha Shin, Matthew J. Everly, Hao Zhang, J. Choi, Ashley Vo, Xiaohai Zhang, Edmund Huang, Stanley C. Jordan & Mieko Toyoda. (2020) Impact of Tocilizumab (Anti–IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-mediated Rejection. Transplantation 104:4, pages 856-863.
Crossref
Belén Atienza-Mateo, Vanesa Calvo-Río, Emma Beltrán, Lucía Martínez-Costa, Elia Valls-Pascual, Marisa Hernández-Garfella, Antonio Atanes, Miguel Cordero-Coma, Joan Miquel Nolla, Carmen Carrasco-Cubero, Javier Loricera, María C González-Vela, Nuria Vegas-Revenga, Carlos Fernández-Díaz, Rosalía Demetrio-Pablo, Lucía C Domínguez-Casas, José Luis Martín-Varillas, Natalia Palmou-Fontana, José L Hernández, Miguel Á González-Gay & Ricardo Blanco. (2018) Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet’s disease: multicentre retrospective study. Rheumatology 57:5, pages 856-864.
Crossref
Stanley C. Jordan, Jua Choi & Ashley Vo. (2015) Kidney transplantation in highly sensitized patients. British Medical Bulletin 114:1, pages 113-125.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.